Compagnie Lombard Odier SCmA’s Histogen Inc. Common Stock HSTO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15	Closed	-$8	–	649
2023 Q3	$8	Hold	15	–	–	﹤0.01%	590
2023 Q2	$11	Hold	15	–	–	﹤0.01%	570
2023 Q1	$18	Hold	15	–	–	﹤0.01%	613
2022 Q4	$0	Hold	15	–	–	﹤0.01%	723
2022 Q3	$0	Buy	+15	New	+$34	﹤0.01%	709
2022 Q2	–	Sell	-15	Closed	–	–	644
2022 Q1	$0	Hold	15	–	–	﹤0.01%	708
2021 Q4	$0	Buy	+15	New	+$172	﹤0.01%	727

Other funds holding HSTO

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Compagnie Lombard Odier SCmA's HSTO Position: Q4 2023 in Review

Compagnie Lombard Odier SCmA sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 15 shares — an estimated $8 sold.

Compagnie Lombard Odier SCmA first reported a position in HSTO in Q4 2021 and held it in 7 quarters. The position peaked at $18 in Q1 2023. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.

Compagnie Lombard Odier SCmA reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 15 Histogen Inc. Common Stock shares in Q4 2023, an estimated $8.
Compagnie Lombard Odier SCmA first reported a position in Histogen Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Compagnie Lombard Odier SCmA's Histogen Inc. Common Stock position peaked at $18 in Q1 2023.
1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2023, filed 16 Jan 2024.